Total Facility Solutions wins contract from Novartis

Published: 14-Sep-2011
Manufacturing Finance

To install hygienic process piping at Vaccines and Diagnostics plant in Holly Springs, NC

Total Facility Solutions, a specialist contractor focused on critical process infrastructure, has been awarded a contract to install hygienic process piping at the Novartis Vaccines and Diagnostics campus in Holly Springs, North Carolina, US.

The order is part of Novartis’ US$36m expansion of its pandemic and seasonal flu production facility, announced last December, which will create 100 new jobs at the Holly Springs development lab and pilot plant.

‘This selection to fabricate and install process piping at Novartis affirms the strength of our model for serving the life science business,’ said Joe Cestari, president of Total Facility Solutions.

‘Having invested heavily in our own North Carolina facility in 2009, we bring the infrastructure, industry expertise and experienced personnel necessary to execute on this project on time, on budget and to specification.’

The project will be operated out of Total Facility Solutions’ Raleigh, NC location, using its 4,000ft2 clean manufacturing space to complete all building work. This plant is equipped with the latest technology for orbital welding and meets stringent market requirements while facilitating just-in-time delivery to the construction site. Bovis Lend Lease and Novartis’ project managers are overseeing the project.

Total Facility Solutions (TFS) provides turnkey facilities contracting services including high-purity piping, gas and chemical systems, ultra-high purity water systems, tool and equipment installation, clean utilities, and electrical services to the semiconductor, electronics, nanotechnology, photovoltaic, life sciences, mission critical, and renewable energy industries.

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Containment

Clean environments: meeting modern drug production challenges

Read more
New medicinal therapies are seeing rapid development but face many price pressures and regulatory challenges. George Wiker, VP, M+W Group and Kurt Gilson, VP, Western US, Total Facility Solutions, discuss the impact on facility design

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  2. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  3. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  4. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The evolution of the CDMO model in Central Europe: strategic partnerships as a catalyst for change As the Central European outsourcing market matures, companies such as Mabion are redefining the CDMO paradigm with integrated biologics expertise and long-term codevelopment partnerships that elevate the region from cost-efficient manufacturer to strategic biopharma collaborator

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Containment

Clean environments: meeting modern drug production challenges

New medicinal therapies are seeing rapid development but face many price pressures and regulatory challenges. George Wiker, VP, M+W Group and Kurt Gilson, VP, Western US, Total Facility Solutions, discuss the impact on facility design
Manufacturing

Total Facility Solutions builds dedicated hygienic fabrication plant

Company will be better positioned to support the high purity piping needs of numerous life science customers
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Design & Build

ESTEVE CDMO expands spray drying and high-potency containment capacity at Girona facility

ESTEVE CDMO has announced plans to add a 3000-square-metre production unit at its Celrà site in Spain to house additional spray drying equipment and high-potency containment suites, with the first new GEA spray dryer due online in Q1 2027
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Oncoinvent patent win and CellCarta deal highlight IP power in oncology innovation

New patent protection for Radspherin and a global exclusivity deal for Aspyre Lung underline how strong IP strategies are driving competitive advantage in cancer therapeutics and diagnostics
Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates
Manufacturing

LabVantage Solutions introduces LabVantage CORTEX, advancing its LIMS platform for AI-driven laboratory operations

Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data. Learn More from LabVantage Leadership at Pittcon 2026
Subscribe now